Advanced Materials · 2023 · 90 citations · 31 references
The cancer-immune cycle conceptualized the mechanisms of driving T cell responses to tumors, but w as limited by immunological ignorance elicited by tumor inherent immunoediting, which failed to initiate and maintain adaptive immunity. Targeting specific vulnerabilities of cell death patterns may provide unique opportunities to boost T cell antitumor immunological effects. Here an ultrasound nanomedicine-triggered tumor immuno-reediting therapeutic strategy using nano/genetically engineered extracellular vesicles, which can induce tumor highly immunogenic PANoptosis and iteratively start-up the energization of cancer innate immunity cycle by repeatedly liberating damage-associated molecular patterns, thereby priming sufficient antigen-specific T cells and shaping protective immune response through activating cGAS-STING signaling pathways, is reported. Aided by immune checkpoint blockade, the reprogramming of immune microenvironment further facilitated a prompt bridging of innate and adaptive immunity, and remarkably suppressed metastatic and rechallenged tumor growth. Thus, targeting PANoptotic cell death provides a catcher against immune escape and a positive-feedback immune activation gateway for overcoming immune resistance to intractable cancers.
31
AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence
SangJoon Lee, Rajendra Karki, Yaqiu Wang et al. · Nature · 2021 · 653 citations · Full text
Succination inactivates gasdermin D and blocks pyroptosis
Fiachra Humphries, Liraz Shmuel-Galia, Natália Ketelut-Carneiro et al. · Science · 2020 · 613 citations · Full text
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Khiem C. Lam, Romina E. Araya, April Huang et al. · Cell · 2021 · 516 citations · Full text
Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense
Min Zheng, Rajendra Karki, Peter Vogel et al. · Cell · 2020 · 495 citations · Full text